Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
grade B 43.85 0.94% 0.41
NTRA closed up 0.94 percent on Friday, May 29, 2020, on 53 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical NTRA trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Golden Cross Bullish 0.94%
NR7 Range Contraction 0.94%
Wide Bands Range Expansion 0.94%
20 DMA Support Bullish 1.34%
Hammer Candlestick Bullish 1.34%
1,2,3 Pullback Bullish Bullish Swing Setup 1.34%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.34%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Medicine Clinical Medicine Medical Tests Medical Genetics Applied Genetics DNA Genetic Testing DNA Paternity Testing In Vitro Fertilization Severe Genetic Diseases

Is NTRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 49.22
52 Week Low 16.87
Average Volume 1,130,213
200-Day Moving Average 35.19
50-Day Moving Average 35.80
20-Day Moving Average 43.18
10-Day Moving Average 44.84
Average True Range 2.40
ADX 32.22
+DI 28.53
-DI 22.80
Chandelier Exit (Long, 3 ATRs ) 42.02
Chandelier Exit (Short, 3 ATRs ) 41.73
Upper Bollinger Band 50.89
Lower Bollinger Band 35.47
Percent B (%b) 0.54
BandWidth 35.71
MACD Line 2.26
MACD Signal Line 2.86
MACD Histogram -0.5959
Fundamentals Value
Market Cap 2.33 Billion
Num Shares 53.2 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -18.05
Price-to-Sales 2.91
Price-to-Book 11.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.66
Resistance 3 (R3) 46.40 45.21 46.19
Resistance 2 (R2) 45.21 44.50 45.34 46.03
Resistance 1 (R1) 44.53 44.05 43.94 44.79 45.88
Pivot Point 43.34 43.34 43.04 43.47 43.34
Support 1 (S1) 42.66 42.63 42.07 42.92 41.82
Support 2 (S2) 41.47 42.18 41.60 41.67
Support 3 (S3) 40.79 41.47 41.51
Support 4 (S4) 41.05